How Is The Market Feeling About Cardinal Health?
Cardinal Health’s (NYSE:CAH) short percent of float has fallen 5.36% since its last report. The company recently reported…
UnitedHealth’s OptumRx Unveils New Transparent Drug Pricing Initiative for 2024
UnitedHealth's OptumRx will implement a new pricing model, OptumRx Clear Trend Guarantee, starting next year.
This Is What Whales Are Betting On Cardinal Health
Whales with a lot of money to spend have taken a noticeably bullish stance on Cardinal Health. Looking…
Peering Into Cardinal Health’s Recent Short Interest
Cardinal Health’s (NYSE:CAH) short percent of float has risen 5.08% since its last report. The company recently reported…
Stocks Set To Snap Worst Losing Streak In Nearly 2 Years, Gold Sinks, Bitcoin Reclaims $66,000: What’s Driving Markets Monday?
U.S. stocks are poised to break a six-day losing streak, marking the end of the longest downward trend since September 2022.
Drug Distributing Giant Cardinal Health Will Not Renew OptumRx Distribution Pact, Stock Plunges
Discover the latest updates on Cardinal Health's nonrenewal of OptumRx contracts. Explore its fiscal 2024 guidance and long-term targets amidst market shifts. Learn about its strategies to offset contract impact and drive growth.
How Is The Market Feeling About Cardinal Health?
Cardinal Health’s (NYSE:CAH) short percent of float has fallen 19.32% since its last report. The company recently reported…
Shake Shack, Cardinal Health And More: CNBC’s ‘Final Trades’
On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management said she likes Invesco S&P 500 Equal Weight Energy ETF (NYSE:
US Federal Trade Commission Investigates Drug Shortages Amid Allegations Of Market Manipulation
FTC probes chemotherapy shortages, scrutinizing drug distributors and hospital groups. Root causes of drug shortages under scrutiny. Industry defends practices.
Precipio And Cardinal Health Sign Distribution Agreement For Its HemeScreen Portfolio Of Molecular Assays For Cancer
Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) announces it has entered into a distribution agreement with Cardinal Health for its HemeScreen molecular assay products. Under the agreement,